Bright Light Therapy to Treat Fatigue in End Stage Kidney Disease
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis. The main aim is to determine if light therapy decreases fatigue severity. Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Signed informed consent prior to initiation of any study mandated procedure
• Male and female participants ≥ 18 years of age
• Diagnosis end stage kidney disease with hemodialysis 3 times/week for at least 1 month
• Fatigue Severity Scale (FSS) \> 9 at enrollment
• Home refrigerator for salivary cortisol storage
Locations
United States
Pennsylvania
University of Pennsylvania
RECRUITING
Philadelphia
Contact Information
Primary
Lea Ann Matura, PhD
matura@nursing.upenn.edu
215 746 8819
Time Frame
Start Date: 2026-02-01
Estimated Completion Date: 2026-08-01
Participants
Target number of participants: 60
Treatments
Experimental: Bright Light
Light therapy will be delivered by the Re-Timer glasses for 60 minutes during dialysis sessions.
Placebo_comparator: Dim Light
Dim light therapy will be delivered by the Re-Timer glasses for 60 minutes during dialysis sessions.
Related Therapeutic Areas
Sponsors
Leads: University of Pennsylvania